Tagged with R

Colombia Rafael Salamanca, the founder of Depósito de Drogas Boyacá, shares his insights on the recent developments of the company in the challenging Colombian logistics environment, while revealing the essence of the company’s success relying on the combination of key factors: product, amount, customer, place and time. You’ve been in the…

Colombia Eduardo Franky Pardo, General Manager of Zambon Colombia, reveals exciting plans on launching the new promising medicine in the recently entered central nervous system therapeutic area, while continuously building their well- reputable presence in Colombia through their philosophy of making quality accessible to everyone. Could you introduce yourself to our…

Colombia Claudio Ferrari, General Manager of Scandinavia Pharma, proudly presents some of the latest product launches of the company and shares insights into the strategic role Scandinavia Pharma plays for Mega Pharma, as an ambitious player aiming to figure amongst the top five companies in the Colombian trade market by 2021.…

Colombia Harold Karam, General Manager of Farma de Colombia, speaks about the implementation of business strategies for the company moving forward, including the growing footprint in the institutional market, while focusing both on own product development and new licensing agreements. Mr. Karam, you have been appointed general manager about four years…

Colombia Emilio Sardi, vice-president of Tecnoquimicas, the local champion in production and distribution of generic pharmaceutical drugs, shares his insights on his current priorities to enter the biotechnology field, grow their international operations focusing on Central American countries and further strengthen the company’s exceptional capacity to launch new products.   The…

Colombia Yolanda Alagón, general manager of Janssen Colombia, discusses the company’s footprint in Colombia and Latin America and her strategy for the affiliate moving forward. You have been appointed General Manager three years ago, becoming one of the first women to lead a pharma company in Latin America. You mentioned your…

Colombia Esteban Lizarazo, CEO of Amarey Group, one of the most vibrant Colombian success stories, shares his insights on the company’s aim to diversify, while introducing the group’s highly innovative business model consisting of world class logistics, high level education and development of close relationships with hospitals. Mr. Lizarazo having worked…

Ukraine Liana Maksyoutova, country manager of Polpharma Ukraine, provides insights into the impressive transformation of the Ukrainian affiliate that she has fostered since inheriting its reins in 2012 and how she has been able to leverage her previous experiences in the Fast-Moving Consumer Goods (FMCG) sector to turn around the affiliate.…

USA Rolando Pablos, Secretary of State of Texas, discusses Texas’s unique business-friendly environment, the significance of the life sciences sector to the state’s economy (which would be the tenth largest in the world were Texas a country), innovation, and internationalization.   Across the board we are industry agnostic, meaning that whatever…

Colombia Alejandro Gaviria Uribe, Colombia’s minister of health and social protection, discusses the implementation of the Statutory Health Law, bridging the gap between healthcare coverage and access to healthcare, and the strategic priorities of the Ministry moving forward. In our 2013 interview, your overarching sentiment was that the healthcare landscape was…

Ukraine Anatoliy Reder, founder and general director of InterChem, provides insights into the heightened international ambitions of this leading, science-based Ukrainian pharmaceutical company, which plans to leverage its unique R&D and manufacturing capacities to bring to the EU and other international markets their in-house developed, original products, which proudly stand as…

Colombia Anant Atal, head of Latin America for Cipla, discusses how the establishment of offices in Colombia was facilitated by its longstanding history in the country, the multiple initiatives the company has engaged in with doctors and patients to improve access to treatments in Respiratory, Oncology and HIV, as well as…